Skip to main content
Allergy Therapeutics plc (AIM:AGY)
London flag London · Delayed Price · Currency is GBP · Price in GBX
11.50
0.00 (0.00%)
At close: Mar 6, 2026

Allergy Therapeutics Revenue

In the fiscal year ending June 30, 2025, Allergy Therapeutics had annual revenue of 55.04M GBP, down -0.28%. Allergy Therapeutics had revenue of 21.01M in the half year ending June 30, 2025, with 6.75% growth.

Revenue
55.04M
Revenue Growth
-0.28%
P/S Ratio
13.23
Revenue / Employee
94.25K
Employees
584
Market Cap
728.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202555.04M-155.00K-0.28%
Jun 30, 202455.20M-4.39M-7.36%
Jun 30, 202359.59M-13.18M-18.11%
Jun 30, 202272.77M-11.56M-13.71%
Jun 30, 202184.33M6.13M7.83%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HUTCHMED (China) 407.54M
Hikma Pharmaceuticals 2.49B
Animalcare Group 81.07M
Shield Therapeutics 30.29M
Venture Life Group 31.23M
ECO Animal Health Group 85.81M
Provexis 871.27K
Haleon 11.03B
Revenue Rankings

Allergy Therapeutics News

More News